2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Are the Primary Drivers Supporting the Market Growth of theOncology Molecular Diagnostics Market?
A rise in cancer cases worldwide is also expected to contribute to the growth of the oncology molecular diagnostics market. The American Cancer Society reported in 2022 about 1.9 million new cancer cases and 609,360 deaths in the U.S., with similar estimates in 2023 (1.96 million new cases and 609,820 deaths). Lung, prostate, bowel, and female breast cancers are the most common globally. As cancer cases continue to rise, the demand for oncology molecular diagnostics is likely to increase.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3457&type=smp
How Has the Oncology Molecular Diagnostics Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?
The oncology molecular diagnostics market size has grown rapidly in recent years. It will grow from $4.84 billion in 2024 to $5.65 billion in 2025 at a compound annual growth rate (CAGR) of 16.7%. The growth drivers include the market entry of early tests, advancements in genomic profiling, next-generation sequencing (NGS) technology, early biomarker identification, and the development of targeted therapies.
The oncology molecular diagnostics market is anticipated to witness rapid expansion, growing to $8.99 billion by 2029 at a CAGR of 12.3%. This growth will be driven by advancements in liquid biopsy, the rise of companion diagnostics, the integration of artificial intelligence (AI), the expansion of next-generation sequencing (NGS) applications, and the evolving identification of biomarkers. Major trends in this market include increased global accessibility, progress in biomarker discovery and validation, refinement of regulatory frameworks, technological advancements, and patient-centered care approaches.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3457
What Are the Key Market Innovations in theOncology Molecular Diagnostics Market Over the Coming Years?
The advanced technology in genomics is a key trend in the oncology molecular diagnostics market. Advancements in cancer genome sequencing technology, computational analysis, tumor models, and innovation of modern cancer research methods promote early detection of cancer and its mutation. For instance, in May 2024, OncoHelix-CoLab, a Canada-based company specializing in precision oncology, focusing on genomic and immunologic profiling for cancer treatment, advanced molecular diagnostics, and immune profile testing laboratory, was launched at Burjeel Medical City in the UAE. This state-of-the-art facility, a collaboration between Burjeel Holdings and OncoHelix, offers extensive capabilities in molecular, cellular immunology, and transplant diagnostics. By conducting complex tests locally, the lab aims to improve diagnostic accuracy and efficiency, eliminating the need to send samples abroad. Its capabilities include sophisticated tests for various cancers, such as prostate cancer, through partnerships like the one with Nanostics for the ClarityDX Prostate test.
Who Are the Major Industry Players Accelerating Growth in theOncology Molecular Diagnostics Market?
Major companies operating in the oncology molecular diagnostics market include F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc., Guardant Health AMEA, Veracyte Inc., Adaptive Biotechnologies Corp., Foundation Medicine Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Genomic Health Inc.
Which Primary Segments of the Oncology Molecular Diagnostics Market Are Driving Growth and Industry Transformations?
The oncology molecular diagnostics market covered in this report is segmented –
1) By Product: Instruments, Reagents, Other Products
2) By Technology: Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies
3) By End User: Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End Users
Subsegments:
1) By Instruments: PCR (Polymerase Chain Reaction) Machines, Sequencers, Microarray Platforms, Fluorescence In Situ Hybridization (FISH) Instruments
2) By Reagents: DNA And RNA Extraction Kits, PCR Reagents And Kits, NGS Library Preparation Kits, Diagnostic Assay Reagents
3) By Other Products: Software For Data Analysis And Interpretation, Quality Control And Calibration Products, Consumables, For Molecular Testing, Biomarkers For Oncology Testing
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=3457&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theOncology Molecular Diagnostics Market?# Market?
The countries covered in the oncology molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
Browse Through More Reports Similar to the Global Oncology Molecular Diagnostics Market 2025, By The Business Research Company:
Microbiology Diagnostic Devices And Equipment Global Market Report 2024
Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2024
Medical And Diagnostic Laboratory Services Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
